Search
for
Sort by
Research 31–60 of 788
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Pharmacological Treatment of Alopecia
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Alopecia areata
- Alopecia Areata: Current Review
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- JAK Inhibitors for Treatment of Alopecia Areata
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Janus kinase inhibitors for alopecia areata: A narrative review